4,4,5,5-TETRAMETHYL-2-(4-((4-(TRIFLUOROMETHYL)BENZYL)OXY)PHENYL)-1,3,2-DIOXABOROLANE, 95%, 250mg

Tos-Gly-OSu, 95.0%, 5g

2-(Thiophen-2-yl)-1H-indole, 95.0%, 250mg

tert-Butyl 4-(3-amino-6-((1S,3S,4S)-4-((tert-butyldimethylsilyl)oxy)-3-fluorocyclohexyl)pyrazin-2-yl)-2-fluorobenzoate, 95%, 250mg

ethyl 6-(decyloxy)-7-ethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate, 98%, 100g

2-(BENZYLTHIO)ACETIC ACID, 97.0%, 10g

3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

(3-Methylpyridin-4-yl)boronic acid hydrochloride, 95.0%, 1g

3,4-Dibromotoluene, 99.0%, 25g

2-(4-Methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>97.0%(GC)(T)5g

1-(2-Methylthiazol-4-yl)ethanone, 95.0%, 10g

(2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid, 95.0%, 1g

2-(tert-Butoxycarbonylthio)-4,6-dimethylpyrimidine [Boc Agent for Peptides Synthesis]>98.0%(T)25g